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dIntroduction
The term desmoplastic malignant melanoma (DMM) was
introduced by Conley et al. in 1971,1 to describe a subset
of cutaneous melanomas characterized by non-pigmented,
spindle cell tumors with pronounced collagenization within
an atypical melanocytic proliferation. Since then, there
have been reports of 16 cases of DMM arising in the mucosa
of the oral cavity.2–10 This is a case report of DMM involving
the alveolus.
Case report
A 32-year-old male was referred to our institution with a
chief complaint of pain and swelling of 20 days duration in741-9409/$ - see front matter c 2006 Elsevier Ltd. All rights reserved
oi:10.1016/j.ooe.2006.08.001
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E-mail address: dr_pratibha@rediffmail.com (P. Ramani).the left posterior maxillary alveolus. The past medical and
dental history was non-contributory. Intra oral examination
revealed an extensive nodular mass of about 4 cm · 5 cm in
size (Fig. 1). It was extending from 24 to 28 region, and the
involved teeth were mobile. The overlying mucosa was of
normal color with ulceration in few areas. The swelling
was soft in consistency. There was no associated
lymphadenopathy.
CT scan revealed an expansile, dense lesion involving
the left maxillary antrum. The lesion was seen extending
medially into the left nasal cavity eroding the lateral wall
of left nasal cavity and also extending intra-orally eroding
the maxilla. The lesion was extending posteriorly into the
pterygopalatine fossa. There was no parapharyngeal
extension. The lesion had eroded the anterior wall of
maxillary antrum with extension into the subcutaneous
tissue. There was thinning of the infraorbital margin.
There was no evidence of calcifications or cystic degener-
ation (Figs. 2 and 3)..
Figure 2 Coronal CT scan shows an expansile mass involving
the left maxillary alveolus and left maxillary antrum.
Figure 3 Axial CT scan shows an expansile mass involving the
left maxillary alveolus.
Figure 4 Photomicrograph shows atypical melanocytes in the
basilar layer of overlying epithelium and spindle as well as
round cells in the connective tissue (H&E), 100·.
Figure 1 Photomicrograph shows the clinical picture with
intraoral swelling involving the left maxillary alveolus.
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melanocytes in single dispersion along the basilar layer
of the overlying epithelium. In addition, widely scattered,
non-pigmented spindle as well as round cells possessing
moderately enlarged nuclei with coarse chromatin
pattern were identified in the connective tissue. There
was an associated prominent stromal desmoplasia (Figs.
4 and 5).
Immuno histochemical staining was performed for S100,
Vimentin, HMB45, CD34, CD68, SMA (Dako Corporation, Car-
penterica, CA) and Pan Cytokeratin (AE1/AE3; Dako Corpo-
ration, Carpenterica, CA).Atypical junctional melanocytes, spindle and round cells
in the connective tissue were strongly positive for S100
(Fig. 6) and vimentin. Cytokeratin was positive for the over-
lying normal epithelium but negative for tumor cells. The
tumor cells did not show any reactivity to HMB45, CD34,
CD68 and SMA.
According to the histological pattern of cells and the
immunohistochemical findings – S-100 (+), Vimentin (+),
Cytokeratin (), HMB45 (), CD34 (), CD68 (), SMA
(), the diagnosis of DMM was made.
The patient was referred for radiotherapy. A dose of 72–
120 Gy was given in fractions over the tumor bed and its
margins. The tumor responded favorably and the patient is
under followup for the past four months.
Figure 5 Photomicrograph shows the junctional proliferation
at the epithelial–connective tissue interface along with few
epitheloid cells in the connective tissue (H&E), 400·.
Figure 6 Photomicrograph shows S100 positivity for spindle
and round cells in the connective tissue (Dako Corporation,
Carpenterica, CA), 400·.
Table 1 Summary of various immunohistochemical findings
in DMM
Author Immunohistochemical
findings
Chen et al. – 198916 Vimentin(+)
S-100()
Antsey et al. – 199415 S-100(+)
NSE(+)
Vimentin(+)
NKIC3(+/)
HMB45(+/)
FXIIIa()
Desmin()
Korabiowska et al. – 199417 S-100(+)
Kilpatrick et al. – 19967 S-100(+)
Vimentin(+)
HMB45(+/)
Prasad et al. – 200118 S-100(+)
Tyrosinase(+)
HMB45(+/)
Melan A(+/)
D5 (Anti-microphthalmia
associated protein)()
Huttenbach et al. – 200219 Peripherin(+/)
p75NGFR(+/)
CD56/N-CAM(+/)
Kay et al. – 200420 Melan A(+)
Tyrosinase(+)
SMA(+)
Prasad et al. – 200410 P53(+)
Kucher et al. – 200421 Melan A(+/)
HMB45(+/)
Yu et al. – 200522 S-100(+)
HMB45(+/)
Melan A(+/)
Radfar et al. – 200623 S-100 weakly positive
NGFR – Intense positive
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In 1971, Conley et al.1 reported a rare variant of spindle cell
melanoma, generally located in the head and neck and
coined the term, ‘‘desmoplastic malignant melanoma’’.
The histogenesis of DMM is unclear. Currently, it is be-
lieved that the desmoplastic component arises from the in-
tra-epidermal melanocytic component and undergoes
reactive fibroplasia into the spindle neoplasm. It is also be-
lieved that these melanoma cells are producing the collagen
(desmoplasia) because some have found fibroblastic and
myofibroblastic differentiation ultrastructurally in these
cells.11
DMM, a subtype of melanoma, is characterized by spindle
cell proliferation in the connective tissue with a collagenous
stroma. There is a wide spectrum in the cellularity and
amount of stromal component varying from abundant colla-
gen (DMM) to minimal collagen (spindle cell melanoma).More than 80% of DMM, have an epidermal component of
melanoma in situ, overlying the dermal component. If pres-
ent, melanin pigment is seen in the epidermal component.
Some do not have epidermal involvement and there is only
a dermal melanocytic spindle cell proliferation. Nuclear
pleomorphism is not typical among the spindle cells but
can be seen at least focally and mitotic figures are rare.12
The melanoma cells of DMM are spindle shaped and amel-
anotic in the vertical growth phase. However, junctional
(dermal–epidermal or lamina propria–epithelial) melano-
cytic proliferation is not always present in DMM.13 In its ab-
sence, the diagnosis of DMM may be particularly difficult.
Patchy, lymphocytic infiltrates of varying density can be
seen in DMM.14
The immunohistochemical profile of DMM differs from
the usual melanomas. The conventional melanoma is
294 P. Ramani et al.typically positive for S100, Melan-A and HMB-45. Most DMM
are S100 positive and negative for Melan-A and HMB-45.12
S100 protein immunostaining is extremely helpful in distin-
guishing DMM from a reactive fibroblastic proliferation.
Immunostaining for cytokeratin clearly separates this tumor
from most squamous cell carcinomas.14 Anstey et al.15 have
proposed that positive or negative labelling for S100 protein
and NSE could be useful for suggesting or excluding a diag-
nosis of DMM. A summary of the various immunohistochem-
ical findings in DMM is summarized in Table 1.
Conclusion
Melanoma can present in different forms and at any ana-
tomic site. This report documents the 17th case of DMM
originating in the oral cavity. This variant of melanoma is
a rare disorder with unremarkable, non-specific clinical
manifestations in the oral cavity, which makes the diagnosis
of this disease more difficult. Hence, an increased aware-
ness, early suspicion and performance of appropriate biopsy
could be of value in early recognition of these variants of
melanoma.
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